General patterns and regional features of epidemiology and the course of ulcerative colitis in the Rostov region


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Aim. The increase in the incidence of ulcerative colitis (UC) increases the need for a deeper study of the peculiarities of this pathology, particular, in the Rostov region, such as the clinical and morphological characteristics of UC, the possibility of remission on the background of various therapy regimens, recurrence of the disease and its complications. Material and methods. A prospective study was performed. 70 patients with UC were included. Clinical and laboratory instrumental studies were carried out, and the effectiveness of various drug therapy regimens was analyzed. Results. It has been established that UC in the Rostov region mainly affects people of working age, in 1/5 of patients a relapse of the disease occurs against the background of the absence of antirelapse therapy. When evaluating laboratory data, an increase in CRP, ESR, anemic syndrome and leukocytosis is noted. The effectiveness of aminosalicylates therapy was 78%, prednisolone and azathioprine 78%, infliximab in combination with azathioprine 80%. Conclusion. The study revealed the dissociation of clinical, morphological and histological remission of UC in the Rostov region, as well as the high efficiency of different therapeutic approaches in compliant UC patients.

全文:

受限制的访问

作者简介

Alexander Tkachev

Rostov State Medical University of the Ministry of Healthcare of Russia

MD, professor, head of the Department of propedeutics of internal medicine

Rozalia Belovolova

Rostov State Medical University of the Ministry of Healthcare of Russia

MD, professor of the Department of propedeutics of internal medicine

Lilit Mkrtchyan

Rostov State Medical University of the Ministry of Healthcare of Russia

associate professor of the Department of propedeutics of internal medicine

Karina Mazovka

Rostov State Medical University of the Ministry of Healthcare of Russia

PhD, associate professor of the Department of propedeutics of internal medicine

参考

  1. Ивашкин В.Т., Шелыгин Ю.А., Белоусова Е.А. с соавт. Проект клинических рекомендаций по диагностике и лечению язвенного колита. Колопроктология. 2019; 4: 7-36. doi: https://doi.org/10.33878/2073-7556-2019-18-4-7-36.
  2. Совалкин В.И., Бикбавова Г.Р., Емельянова Ю.А. Современный взгляд на патогенез и лабораторную диагностику язвенного колита (обзор литературы). Архивъ внутренней медицины. 2017; 4: 252-259. doi: https://doi.org/10.20514/2226-6704-2017-7-4-252-259.
  3. Фиокки К. Этиопатогенез воспалительных заболеваний кишечника. Колопроктология. 2015; 1: 5-20.
  4. Белоусова Е.А., Абдулганиева Д.И., Алексеева О.П. с соавт. Социально-демографическая характеристика, особенности течения и варианты лечения воспалительных заболеваний кишечника в России. Результаты двух многоцентровых исследований. Альманах клинической медицины. 2018; 5: 445-463. doi: https://dx.doi.org/10.18786/2072-0505-2018-46-5-445-463.
  5. Халиф И.Л., Шапина М.В., Головенко А.О. с соавт. Течение хронических воспалительных заболеваний кишечника и методы их лечения, применяемые в Российской Федерации (результаты многоцентрового популяционного одномоментного наблюдательного исследования). Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2018; 3: 54-62. doi: https://dx.doi.org/10.22416/1382-4376-2018-28-3-54-62.
  6. Harbord M., Eliakim R., Bettenworth D. et al. European Crohn's and Colitis Organisation (ECCO). Third European Evidence-based Consensus on diagnosis and management of ulcerative colitis. Part 2: Current management. J. Crohns Colitis. 2017; 11(7): 769-84. doi: 10.1093/ecco-jcc/jjx009.

补充文件

附件文件
动作
1. JATS XML

版权所有 © Bionika Media, 2021
##common.cookie##